Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma

NCT04202523 is registered in ClinicalTrials.gov with Guangxi Medical University as lead sponsor.

NCT NCT04202523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04202523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma
Lead sponsor
Guangxi Medical University
Phase
Phase 3
Overall status
Unknown status
Start date
December 1, 2019
Completion date
December 31, 2020
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma